sections

Tuesday, 17 October 2017

Anthony Hughes' s stories

Sort by: Newest firstOldest firstA-ZZ-A

  • Market turn presents ECM challenges

    Equities | 24 March 2017

    Tuesday’s US stock market sell-off, the biggest fall in the major averages so far in 2017, gave ECM syndicate desks and investors reason for pause and cast a cloud over the near-term deal pipeline.

  • Alteryx secures top-end pricing

    Equities | 24 March 2017

    Alteryx drew more than 20 times subscription for its US$126m IPO last week, with the overflowing demand ensuring the self-service data analytics software company made a solid NYSE debut on Friday.

  • Keysight secures US$400m for Ixia buy

    Equities | 24 March 2017

    Keysight Technologies defied a sharp market decline last week to price a US$400m stock sale, the company’s first visit to equity capital markets since being spun off from Agilent Technologies in 2014.

  • Abbott slices Mylan stake with $1.7bn block

    Equities | 24 March 2017

    Abbott Laboratories has sold more than 60% of its remaining stake in EpiPen maker Mylan in a US$1.76bn unregistered block trade via Morgan Stanley, one of the largest ever stock sales in this format.

  • Cherry Hill stock sale blossoms too early

    Equities | 24 March 2017

    Mortgage REIT Cherry Hill Mortgage inadvertently gave eagle-eyed investors a premature heads-up on a US$74.3m follow-on stock sale launched after the close on Wednesday.

  • Abbott offloads Mylan stake via US$1.7bn overnight block

    Ticker | 23 March 2017

    Abbott Laboratories has sold more than 60% of its remaining stake in EpiPen maker Mylan in a US$1.7bn unregistered block trade via Morgan Stanley, one of the largest-ever commitments in this format.

  • Keysight pre-funds Ixia acquisition

    Ticker | 21 March 2017

    Keysight Technologies launched a US$400m marketed equity raise late Monday, its first as an independent entity since being spun off from Agilent Technologies in 2014.

  • Alteryx IPO oversubscribed ahead of pricing this week

    Ticker | 20 March 2017

    The US$126m IPO of self-service data software provider Alteryx is oversubscribed ahead of pricing Thursday, a banker close to the deal told IFR.

  • Bill Ackman, chief executive officer and portfolio manager of Pershing Square Capital Management, L.P.

    Ackman feels more pain on Valeant exit

    Top News | 17 March 2017

    The painful decline in the prospects and share price of Valeant Pharmaceuticals International has proved too much to bear for its most ardent supporter, billionaire hedge fund activist Bill Ackman.

  • MuleSoft IPO buoys software valuations

    Equities | 17 March 2017

    Application network software maker MuleSoft recalled the heyday of soaring software valuations in 2013-2014 by lifting its IPO marketing range, pricing above this range, and soaring on its NYSE debut on Friday.